Keyphrases
Meta-analysis
100%
Systematic Meta-analysis
100%
Multidrug-resistant Tuberculosis (MDR-TB)
100%
Sudan
100%
Anti-TB Drugs
50%
TB Control
50%
Antibiotics
25%
Scopus
25%
High Prevalence
25%
Ofloxacin
25%
Drug Resistance
25%
Treatment Strategy
25%
Prevalence Estimation
25%
Resistance Prevalence
25%
Second-line Drugs
25%
Streptomycin
25%
Multidrug Resistance
25%
Newly Diagnosed
25%
Web of Science
25%
Control Strategy
25%
Kanamycin
25%
Rifampicin
25%
Prevalence Data
25%
PubMed
25%
Google Scholar
25%
TB Patients
25%
First-line Anti-tuberculosis Drugs
25%
Pooled Prevalence
25%
Resistance Profile
25%
Previously Treated Patients
25%
Control Effort
25%
TB Treatment
25%
Extensive Drug Resistance
25%
TB Cases
25%
Neuroscience
Meta-Analysis
100%
Drug Resistance
66%
Isoniazid
33%
Rifampicin
33%
Kanamycin
33%
Streptomycin
33%
Ofloxacin
33%
Pharmacology, Toxicology and Pharmaceutical Science
Prevalence
100%
Drug Resistant Tuberculosis
100%
Drug Resistance
28%
Ofloxacin
14%
Antibiotics
14%
Isoniazid
14%
Kanamycin
14%
Streptomycin
14%
Rifampicin
14%
Biochemistry, Genetics and Molecular Biology
Prevalence
100%
Drug Resistance
28%
Medline
14%
Streptomycin
14%
Kanamycin
14%
Ofloxacin
14%
Web of Science
14%
Scopus
14%
Immunology and Microbiology
Prevalence
100%
Drug Resistance
28%
Medline
14%
Web of Science
14%
Scopus
14%